CosmosID Competitors and Similar CompaniesClear all

Metabolon's competitors and similar companies include Adaptimmune and PolyPid.
Metabolon
Metabolon
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
PolyPid
PolyPid
PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).
Founding Date
Founding Date
2000
Founding Date
2008
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Morrisville, US HQ
Hallbergmoos, DE
München, DE
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Locations
Petah Tikva, IL HQ
Summit, US
Employees
Employees
1911% increase
Employees
4007% decrease
Employees
57
Valuation ($)
Valuation ($)
N/A
Valuation ($)
188.5 m
Valuation ($)
23.7 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$178m (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$70k (FY, 2024)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$178m (FY, 2024)
Gross profit
N/A
Net income
Net income
N/A
Net income
($70.8m) (FY, 2024)
Net income
($34.2m) (FY, 2025)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
69 (FY, 2016)
Patent Applications
49 (FY, 2017)
Patents Issued
Patents Issued
N/A
Patents Issued
173 (FY, 2016)
Patents Issued
104 (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 95.4m
Total funding raised
$ 107.5m
Total funding raised
$ 103.8m
For sources of this data, please see the company profile

View Company Profiles

Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

View company
PolyPid
HQ
Petah Tikva, IL
Employees
57

PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).

View company